Part 3.1 / M1, M8, M11
3. DEEL 3: GEHARMONISEERDE INDELING EN ETIKETTERING
|
Catalogusnummer |
►M18 Chemische naam ◄ |
EG-nr. |
CAS-nr. |
Indeling |
Etikettering |
►M18 Specifieke concentratiegrenzen, M-factoren en ATE's (*1) ◄ |
Opmerkingen |
|||
|
Gevarenklasse en -categorie |
Gevarenaanduiding |
Pictogram, signaalwoord |
Gevarenaanduiding |
Aanvullende gevarenaanduiding |
||||||
|
015-003-00-2 |
calciumfosfide; tricalciumdifosfide |
215-142-0 |
Water ontvl. 1 Acute tox. 2 Acute tox. 3 Acute tox. 1 Oogletsel 1 Aquatisch acuut 1 |
H260 H300 H311 H330 H318 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H260 H300 H311 H330 H318 H400 |
EUH029 EUH032 |
M = 100 |
|
|
|
019-003-00-3 |
kalium-(E,E)-hexa-2,4-dienoaat |
246-376-1 |
Oogirrit. 2 |
H319 |
GSH07 Wng |
H319 |
|
|
|
|
|
031-001-00-4 |
galliumarsenide |
215-114-8 |
Repr. 1B Carc. 1B STOT RE 1 |
H360F H350 H372 (ademhalingssysteem en hematopoëtisch systeem) |
GHS08 Dgr |
H360F H350 H372 (ademhalingssysteem en hematopoëtisch systeem) |
|
|
|
|
|
050-008-00-3 |
tributyltinverbindingen, met uitzondering van de elders in deze bijlage met name genoemde |
— |
— |
Repr. 1B Acute tox. 3 Acute tox. 4* STOT RE 1 Huidirrit. 2 Oogirrit. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H360FD H301 H312 H372** H315 H319 H400 H410 |
GHS08 GHS06 GHS09 Dgr |
H360FD H301 H312 H372** H315 H319 H410 |
|
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Huidirrit. 2; H315: C ≥ 1 % Oogirrit. 2; H319: C ≥ 1 % M = 10 |
A 1 |
|
603-102-00-9 |
1,2-epoxybutaan |
203-438-2 |
Ontvlm. vlst. 2 Carc. 2 Acute tox. 4* Acute tox. 4* Acute tox. 4* STOT SE 3 Huidirrit. 2 Oogirrit. 2 |
H225 H351 H302 H312 H332 H335 H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H302 H312 H332 H335 H315 H319 |
|
|
|
|
|
603-197-00-7 |
tebuconazool (ISO); 1-(4-chloorfenyl)-4,4-dimethyl-3-(1,2,4-triazool-1-ylmethyl)pentaan-3-ol |
403-640-2 |
Repr. 2 Acute tox. 4 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d*** H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H302 H410 |
|
M = 1 M = 10 |
|
|
|
606-054-00-7 |
isoxaflutool (ISO); 5-cyclopropyl-1,2-oxazol- 4-yl α,α,α-trifluor-2-mesyl-p-tolylketon |
— |
Repr. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d*** H400 H410 |
GHS08 GHS09 Wng |
H361d*** H410 |
|
M = 10 M = 100 |
|
|
|
606-148-00-8 |
carvon (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1] d-carvon; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2] l-carvon; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3] |
202-759-5 [1] 218-827-2 [2] 229-352-5 [3] |
99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] |
Huidgev. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
606-149-00-3 |
tembotrion (ISO); 2-{2-chloor-4-(methylsulfonyl)-3-[(2,2,2-trifluoorethoxy)methyl]benzoyl}cyclohexaan-1,3-dion |
— |
Repr. 2 STOT RE 2 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d H373 (ogen, nieren, lever) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (ogen, nieren, lever) H317 H410 |
|
M = 100 M = 10 |
|
|
|
607-197-00-8 |
nonaanzuur |
203-931-2 |
Huidirrit. 2 Oogirrit. 2 Aquatisch chronisch 3 |
H315 H319 H412 |
GHS07 Wng |
H315 H319 H412 |
|
|
|
|
|
607-707-00-9 |
fenoxaprop-P-ethyl (ISO); ethyl-(2R)-2-{4-[(6-chloor-1,3-benzoxazol-2-yl)oxy]fenoxy}propanoaat |
— |
STOT RE 2 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H373 (nieren) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 (nieren) H317 H410 |
|
M = 1 M = 1 |
|
|
|
607-708-00-4 |
octaanzuur |
204-677-5 |
Huidcorr. 1C Aquatisch chronisch 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
|
|
607-709-00-X |
decaanzuur |
206-376-4 |
Huidirrit. 2 Oogirrit. 2 Aquatisch chronisch 3 |
H315 H319 H412 |
GHS07 Wng |
H315 H319 H412 |
|
|
|
|
|
607-710-00-5 |
1,2-benzeendicarbonzuur, dihexylester, vertakt en lineair |
271-093-5 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
|
|
607-711-00-0 |
spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylfenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl-ethylcarbonaat |
— |
Repr. 2 STOT SE 3 Oogirrit. 2 Huidgev. 1 A Aquatisch acuut 1 Aquatisch chronisch 1 |
H361fd H335 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H335 H319 H317 H410 |
|
M = 1 M = 1 |
|
|
|
607-712-00-6 |
dodemorfacetaat; 4-cyclododecyl-2,6-dimethylmorfoline-4-ium-acetaat |
250-778-2 |
Repr. 2 STOT RE 2 Huidcorr. 1C Huidgev. 1 A Aquatisch chronisch 1 |
H361d H373 (lever) H314 H317 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d H373 (lever) H314 H317 H410 |
EUH071 |
M = 1 |
|
|
|
607-713-00-1 |
fenpyroximaat (ISO); tert-butyl-4-[({(E)-[(1,3-dimethyl-5-fenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoaat |
— |
Acute tox. 3 Acute tox. 2 Huidgev. 1B Aquatisch acuut 1 Aquatisch chronisch 1 |
H301 H330 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H330 H317 H410 |
|
M = 100 M = 1 000 |
|
|
|
607-714-00-7 |
triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluoorethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoaat |
— |
Carc. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 100 M = 10 |
|
|
|
607-715-00-2 |
bifenazaat (ISO); isopropyl-2-(4-methoxybifenyl-3-yl)hydrazinocarboxylaat |
442-820-5 |
STOT RE 2 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H373 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 H317 H410 |
|
M = 1 M = 1 |
|
|
|
613-042-00-5 |
imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichloorfenyl)ethyl]-1H-imidazool |
252-615-0 |
Carc. 2 Acute tox. 3 Acute tox. 4 Ooglets. 1 Aquatisch chronisch 1 |
H351 H301 H332 H318 H410 |
GHS08 GHS06 GHS05 GHS09 Dgr |
H351 H301 H332 H318 H410 |
|
M = 10 |
|
|
|
613-057-00-7 |
dodemorf (ISO); 4-cyclododecyl-2,6-dimethylmorfoline |
216-474-9 |
Repr. 2 STOT RE 2 Huidcorr. 1C Huidgev. 1A Aquatisch acuut 1 Aquatisch chronisch 1 |
H361d H373 (lever) H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d H373 (lever) H314 H317 H410 |
EUH071 |
M = 1 M = 1 |
|
|
|
613-133-00-X |
etridiazool (ISO); 5-ethoxy-3-trichloormethyl-1,2,4-thiadiazool |
219-991-8 |
Carc. 2 Acute tox. 4 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H351 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H317 H410 |
|
M = 1 M = 1 |
|
|
|
613-149-00-7 |
pyridabeen (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloorpyridazine-3(2H)-on |
405-700-3 |
Acute tox. 3 Acute tox. 3 Aquatisch acuut 1 Aquatisch chronisch 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
M = 1 000 M = 1 000 |
|
|
|
613-319-00-0 |
imidazool |
206-019-2 |
Repr. 1B Acute tox. 4 Huidcorr. 1C |
H360D H302 H314 |
GHS08 GHS07 GHS05 Dgr |
H360D H302 H314 |
|
|
|
|
|
613-320-00-6 |
lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dion |
218-499-0 |
Carc. 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 10 M = 10 |
|
|
|
616-213-00-2 |
mandipropamid (ISO); 2-(4-chloorfenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)fenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide |
— |
Aquatisch acuut 1 Aquatisch chronisch 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1 M = 1 |
|
|
|
616-214-00-8 |
metosulam (ISO); N-(2,6-dichloor-3-methylfenyl)-5,7-dimethoxy[1,2,4]triazool[1,5-a]pyrimidine-2-sulfonamide |
— |
Carc. 2 STOT RE 2 Aquatisch acuut 1 Aquatisch chronisch 1 |
H351 H373 (ogen, nieren) H400 H410 |
GHS08 GHS09 Wng |
H351 H373 (ogen, nieren) H410 |
|
M = 1 000 M = 100 |
|
|
|
616-215-00-3 |
dimethenamid-P (ISO); 2-chloor-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropaan-2-yl]acetamide |
— |
Acute tox. 4 Huidgev. 1 Aquatisch acuut 1 Aquatisch chronisch 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M = 10 M = 10 |
|
|
|
616-216-00-9 |
flonicamide (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide |
— |
Acute tox. 4 |
H302 |
GHS07 Wng |
H302 |
|
|
|
|
|
616-217-00-4 |
sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylideen]cyanamide |
— |
Acute tox. 4 Aquatisch acuut 1 Aquatisch chronisch 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 1 M = 1 |
|
|